RP101 (RESprotect)

N/A

Report date: 2025/08/20 16:51:14
NME

Base Information

Drug NameRP101 (RESprotect)
Drug Alias NameRP101 (RESprotect)RP-101 (RESprotect)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHeat shock protein beta-1 inhibitors
TargetsHeat shock protein beta-1
Therapy Area/IndicationsSolid tumoursPancreatic NeoplasmsCommunicable Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesResprotect
China Registration ClassN/A

Develop Information

Active CompaniesResprotect
Inactive CompaniesN/A
Active IndicationsSolid tumoursPancreatic NeoplasmsCommunicable Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A